⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AVIR News
Atea Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
AVIR
Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
AVIR
Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference Call on March 5, 2026
globenewswire.com
AVIR
Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026
globenewswire.com
AVIR
AvAir Earns Parts Supplier of the Year for an Unprecedented Sixth Consecutive Year USA - English USA - English
prnewswire.com
AVIR
AvAir Earns Parts Supplier of the Year for an Unprecedented Sixth Consecutive Year USA - English USA - English
prnewswire.com
AVIR
AvAir Announces Promotion of Zach Hall to Senior Vice President of Commercial USA - English USA - English
prnewswire.com
AVIR
AvAir Appoints Tyler Botthof as Chief Operating Officer USA - English USA - English
prnewswire.com
AVIR
Atea Pharmaceuticals to Highlight 2026 Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
AVIR
Atea Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
AVIR